Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Elevated serum levels of sialyl Lewis X (sLeX) and inflammatory mediators in patients with breast cancer.

Cohen EN, Fouad TM, Lee BN, Arun BK, Liu D, Tin S, Gutierrez Barrera AM, Miura T, Kiyokawa I, Yamashita J, Alvarez RH, Valero V, Woodward WA, Shen Y, Ueno NT, Cristofanilli M, Reuben JM.

Breast Cancer Res Treat. 2019 Aug;176(3):545-556. doi: 10.1007/s10549-019-05258-0. Epub 2019 May 3.

PMID:
31054033
2.
3.

Involvement of carbohydrate antigen sialyl Lewis(x) in colorectal cancer metastasis.

Nakamori S, Kameyama M, Imaoka S, Furukawa H, Ishikawa O, Sasaki Y, Izumi Y, Irimura T.

Dis Colon Rectum. 1997 Apr;40(4):420-31.

PMID:
9106690
4.
5.

Prognostic role of serum sialyl Lewisx (CD15s) in colorectal cancer.

Paganuzzi M, Bobbio B, Marroni P, Filiberti R, Secco GB, Grossi CE.

Oncology. 2003;65(1):52-9.

PMID:
12837983
6.

Elevated serum RAS p21 is an independent prognostic factor in metastatic breast cancer.

Banys-Paluchowski M, Fehm T, Janni W, Aktas B, Fasching PA, Kasimir-Bauer S, Milde-Langosch K, Pantel K, Rack B, Riethdorf S, Solomayer EF, Witzel I, Müller V.

BMC Cancer. 2018 May 8;18(1):541. doi: 10.1186/s12885-018-4282-0.

7.

Is Sialyl Lewis x antigen expression a prognostic factor in patients with breast cancer?

Sozzani P, Arisio R, Porpiglia M, Benedetto C.

Int J Surg Pathol. 2008 Oct;16(4):365-74. doi: 10.1177/1066896908324668.

PMID:
18977761
8.

Increased expression of sialyl-Lewis A correlates with poor survival in upper urinary tract urothelial cancer patients.

Saito K, Fujii Y, Kawakami S, Hayashi T, Arisawa C, Koga F, Kageyama Y, Kihara K.

Anticancer Res. 2003 Jul-Aug;23(4):3441-6.

PMID:
12926087
9.

Sialyl Lewis antigens: association with MUC5AC protein and correlation with post-operative recurrence of non-small cell lung cancer.

Yu CJ, Shih JY, Lee YC, Shun CT, Yuan A, Yang PC.

Lung Cancer. 2005 Jan;47(1):59-67.

PMID:
15603855
10.

The prognostic value of the Tau protein serum level in metastatic breast cancer patients and its correlation with brain metastases.

Darlix A, Hirtz C, Thezenas S, Maceski A, Gabelle A, Lopez-Crapez E, De Forges H, Firmin N, Guiu S, Jacot W, Lehmann S.

BMC Cancer. 2019 Jan 30;19(1):110. doi: 10.1186/s12885-019-5287-z.

11.

Inflammatory cytokines regulate the expression of glycosyltransferases involved in the biosynthesis of tumor-associated sialylated glycans in pancreatic cancer cell lines.

Bassagañas S, Allende H, Cobler L, Ortiz MR, Llop E, de Bolós C, Peracaula R.

Cytokine. 2015 Sep;75(1):197-206. doi: 10.1016/j.cyto.2015.04.006. Epub 2015 Apr 28.

PMID:
25934648
12.

Expression of carbohydrate antigen sialyl Le(a): a new functional prognostic factor in gastric cancer.

Nakamori S, Furukawa H, Hiratsuka M, Iwanaga T, Imaoka S, Ishikawa O, Kabuto T, Sasaki Y, Kameyama M, Ishiguro S, Irimura T.

J Clin Oncol. 1997 Feb;15(2):816-25.

PMID:
9053509
13.

Preoperative serum levels of sialyl Lewis(a), sialyl Lewis(x), and sialyl Tn antigens as prognostic markers after curative resection for colorectal cancer.

Nakagoe T, Sawai T, Tsuji T, Jibiki MA, Nanashima A, Yamaguchi H, Yasutake T, Kurosaki N, Ayabe H, Arisawa K.

Cancer Detect Prev. 2001;25(3):299-308.

PMID:
11425272
14.
15.

[Clinical value of carbohydrate antigens, sialyl Lewis-x and sialyl Lewis-a in gastrointestinal cancer].

Nakamori S, Arai I, Okamura S, Imaoka S, Furukawa H, Kabuto T, Ishikawa O, Sasaki Y, Kameyama M, Iwanaga T.

Nihon Geka Gakkai Zasshi. 1996 Feb;97(2):165-71. Review. Japanese.

PMID:
8632746
16.

Prospective evaluation of serum tissue inhibitor of metalloproteinase 1 and carbonic anhydrase IX in correlation to circulating tumor cells in patients with metastatic breast cancer.

Müller V, Riethdorf S, Rack B, Janni W, Fasching PA, Solomayer E, Aktas B, Kasimir-Bauer S, Zeitz J, Pantel K, Fehm T; DETECT study group.

Breast Cancer Res. 2011 Jul 11;13(4):R71. doi: 10.1186/bcr2916.

17.

Identification of potential pancreatic cancer serum markers: Increased sialyl-Lewis X on ceruloplasmin.

Balmaña M, Sarrats A, Llop E, Barrabés S, Saldova R, Ferri MJ, Figueras J, Fort E, de Llorens R, Rudd PM, Peracaula R.

Clin Chim Acta. 2015 Mar 10;442:56-62. doi: 10.1016/j.cca.2015.01.007. Epub 2015 Jan 14.

PMID:
25595436
18.

sLea and sLex expression in colorectal cancer: implications for tumourigenesis and disease prognosis.

Portela SV, Martín CV, Romay LM, Cuevas E, Martín EG, Briera AF.

Histol Histopathol. 2011 Oct;26(10):1305-16. doi: 10.14670/HH-26.1305.

PMID:
21870334
19.
20.

Assessment of circulating tumor cells and serum markers for progression-free survival prediction in metastatic breast cancer: a prospective observational study.

Bidard FC, Hajage D, Bachelot T, Delaloge S, Brain E, Campone M, Cottu P, Beuzeboc P, Rolland E, Mathiot C, Pierga JY.

Breast Cancer Res. 2012 Feb 13;14(1):R29.

Supplemental Content

Support Center